These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9697673)

  • 21. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.
    Topley N; Kaur D; Petersen MM; Jörres A; Williams JD; Faict D; Holmes CJ
    J Am Soc Nephrol; 1996 Feb; 7(2):218-24. PubMed ID: 8785390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
    Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
    Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.
    Cooker LA; Luneburg P; Holmes CJ; Jones S; Topley N;
    Perit Dial Int; 2001; 21 Suppl 3():S102-7. PubMed ID: 11887802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.
    Vila Cuenca M; Keuning ED; Talhout W; Paauw NJ; van Ittersum FJ; Ter Wee PM; Beelen RHJ; Vervloet MG; Ferrantelli E
    Int Urol Nephrol; 2018 Jun; 50(6):1151-1161. PubMed ID: 29728994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
    Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
    Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.
    Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
    Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
    Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
    Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
    Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
    Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro biocompatibility evaluation of a novel bicarbonate-buffered amino-acid solution for peritoneal dialysis.
    Jörres A; Gahl GM; Ludat K; Frei U; Passlick-Deetjen J
    Nephrol Dial Transplant; 1997 Mar; 12(3):543-9. PubMed ID: 9075138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of advanced glycation end-products and aminoguanidine on TNFalpha production by rat peritoneal macrophages.
    Rashid G; Luzon AA; Korzets Z; Klein O; Zeltzer E; Bernheim J
    Perit Dial Int; 2001; 21(2):122-9. PubMed ID: 11330554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis.
    Hoshino T; Kaneko S; Minato S; Yanai K; Mutsuyoshi Y; Ishii H; Kitano T; Shindo M; Miyazawa H; Aomatsu A; Ito K; Ueda Y; Hirai K; Ookawara S; Morishita Y
    Ther Apher Dial; 2018 Dec; 22(6):641-648. PubMed ID: 30014626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system.
    Fusshoeller A; Baehr J; Grabensee B; Plum J
    Perit Dial Int; 2005; 25(4):387-93. PubMed ID: 16022097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes.
    Plum J; Lordnejad MR; Grabensee B
    Kidney Int; 1998 Jul; 54(1):224-35. PubMed ID: 9648083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.
    Brulez HF; Dekker HA; Oe PL; Verbeelen D; ter Wee PM; Verbrugh HA
    Nephron; 1996; 74(1):26-32. PubMed ID: 8883016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro effects of amino-acid-based versus glucose-based continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Schenk U; Kiefer T; Hübel E; Weber J; Mettang T; Passlick-Deetjen J; Kuhlmann U
    Nephron; 1994; 68(3):338-46. PubMed ID: 7838257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.
    Jörres A; Gahl GM; Topley N; Neubauer A; Ludat K; Müller C; Passlick-Deetjen J
    Nephrol Dial Transplant; 1994; 9(7):785-90. PubMed ID: 7970120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the dialysis fluid buffer on peritoneal membrane function in children.
    Schmitt CP; Nau B; Gemulla G; Bonzel KE; Hölttä T; Testa S; Fischbach M; John U; Kemper MJ; Sander A; Arbeiter K; Schaefer F
    Clin J Am Soc Nephrol; 2013 Jan; 8(1):108-15. PubMed ID: 23124784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution.
    Weiss L; Stegmayr B; Malmsten G; Tejde M; Hadimeri H; Siegert CE; Ahlmén J; Larsson R; Ingman B; Simonsen O; van Hamersvelt HW; Johansson AC; Hylander B; Mayr M; Nilsson PH; Andersson PO; De los Ríos T
    Perit Dial Int; 2009; 29(6):647-55. PubMed ID: 19910566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.